title: Necrotizing fasciitis following drainage of Streptococcus milleri empyema.
abstract: Streptococcus milleri (SM) is a heterogeneous group of Streptococci, which is a recognized cause of purulent infections of the mediastinal and pleural spaces. These infections are notoriously resistant and require aggressive surgical management. We present our experience with a 60-year-old patient, who developed necrotizing fasciitis of the chest wall after initial bedside drainage of a SM empyema. He required extensive debridement with significant soft tissue loss and subsequent latissimus dorsi flap reconstruction to cover the defect.
authors.affiliation: Department of Thoracic Surgery, St. James's Hospital, Leeds, UK. pcherv@hotmail.com
authors.forename: Peter
authors.initials: P
authors.lastname: Tcherveniakov
authors.forename: Eirik
authors.initials: E
authors.lastname: Svennevik
authors.forename: Kallirroi
authors.initials: K
authors.lastname: Tzafetta
authors.forename: Richard
authors.initials: R
authors.lastname: Milton
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003646:Debridement; D004322:Drainage / Q000009:adverse effects*; D016724:Empyema, Pleural / Q000188:drug therapy / Q000382:microbiology / Q000601:surgery*; D019115:Fasciitis, Necrotizing / Q000382:microbiology* / Q000628:therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D054843:Negative-Pressure Wound Therapy; D013290:Streptococcal Infections / Q000188:drug therapy / Q000382:microbiology / Q000601:surgery*; D034364:Streptococcus milleri Group / Q000302:isolation & purification*; D013524:Surgical Flaps; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents